| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_930c0d714758369d228906540e8bd456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7115ef17a0cce55f36229865e31ea6a0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 |
| filingDate |
1999-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cff6ff49607d5a28030da4bd0daeb31 |
| publicationDate |
2000-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0038690-A2 |
| titleOfInvention |
Prostaglandin e agonists for treatment of dry eye |
| abstract |
Compositions and methods for the treatment of dry eye and related diseases in mammals utilizing prostaglandin E receptor agonists are disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014069401-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0038663-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0105388-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0105388-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7396946-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2465537-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6566398-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9968716-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009007360-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0038663-A2 |
| priorityDate |
1998-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |